Membrane-camouflaged supramolecular nanoparticles for co-delivery of chemotherapeutic and molecular-targeted drugs with siRNA against patient-derived pancreatic carcinoma

• Main Authors: Honglin Tang (Author), Yanan Xue (Author), Bowen Li (Author), Xiaojie Xu (Author), Fu Zhang (Author), Jiajing Guo (Author), Qijun Li (Author), Tingting Yuan (Author), Yuan Chen (Author), Yubin Pan (Author), Yuan Ping (Author), Da Li (Author)
• Format: Book
• Published: Elsevier, 2022-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Pancreatic cancer remains one of the most lethal malignancies worldwide. The combination of the first-line standard agent gemcitabine (GEM) with the molecular-targeted drug erlotinib (Er) has emerged as a promising strategy for pancreatic cancer treatment. However, the clinical benefit from this com...